Skip to main content

Table 4 Convergent and Divergent Validity at baseline and at 3–16 weeks after treatment

From: eCross-cultural adaptation of the spine oncology-specific SOSGOQ2.0 questionnaire to German language and the assessment of its validity and reliability in the clinical setting

Domains

Surgery ±CTx/RTx

N

CTx/RTx Only

N

All Patients

N

Item Own Domain Correlation

Item Other Domain Correlation

Item Own Domain Correlation

Item Other Domain Correlation

Item Own Domain Correlation

Item Other Domain Correlation

Physical Functioning

0.71–0.88

0.24–0.38

83

0.78–0.90

0.40–0.62

35

0.74–0.88

0.27–0.46

113

0.39–0.87

0.51–0.64

20

0.65–0.90

0.53–0.61

41

0.75–0.92

0.58–0.64

82

Pain

0.70–0.83

0.37–0.58

83

0.82–0.89

0.51–0.69

35

0.75–0.87

0.45–0.58

113

0.65–0.86

0.51–0.58

20

0.75–0.87

0.56–0.70

41

0.75–0.87

0.54–0.58

82

Mental Health / Cognitive Functioning

0.79–0.90

0.35–0.58

83

0.75–0.79

0.58–0.77

35

0.81–0.84

0.42–0.58

113

0.78–0.84

0.58–0.64

20

0.88–0.89

0.53–0.70

41

0.87–0.88

0.58–0.67

82

Social Functioning

0.55–0.80

0.24–0.49

83

0.51–0.87

0.40–0.77

35

0.54–0.81

0.27–0.47

113

0.58–0.92

0.53–0.64

20

0.49–0.83

0.61–0.65

41

0.53–0.83

0.54–0.67

82

  1. Abbreviations: CTx chemotherapy, RTx radiotherapy, first line shows the values from the baseline survey (T1), second line with gray background shows the values for the follow-up (T3); values printed in bold mark overlaps between the domains; N number of patients